JPMorgan lowered the firm's price target on Alkami to $19 from $20 and keeps an Overweight rating on the shares. The firm rolled forward its price targets to December 2027 from December 2026 across its banking technology and digital banking coverage. JPMorgan has a constructive view on the group, saying "AI-defensibility concerns appear overstated relative to the entrenched workflow, data, and compliance moats these vendors have built." The firm's highest conviction ideas remain Q2 and Alkami. The companies operate in a consolidated, duopolistic digital banking market with long contract durations, strong retention, and paths to free cash flow expansion, the analyst tells investors in a research note. JPMorgan adds that Alkami. screens as its "high-conviction takeout candidate" amid activist pressure.
